Ondansetron as a Cause of Transient Blindness: A Case Report

REPORTpantoprazole 40 mg IV twice a day, injection ondansetron 4 mg thrice a day, tablet amlodipine 10 mg twice a day, and tablet baclofen 25 mg twice a day.The patient was improving with the treatment and was mobilized out of bed on the 3rd day of admission.However, on the 4th day of admission, the patient suddenly complained of a loss of vision.Her vitals were normal, and no other abnormality was detected.The patient had been administered intravenous ondansetron 4 mg 10 minutes prior to the onset of blindness.The patient experienced vertigo and sudden blackout, with everything appearing greenish.A neurology consultation was sought.The neurological examination was normal, other than the blindness.However, the patient was agitated and restless.A provisional diagnosis of encephalopathy/acute psychosis was made.Color Doppler of carotid and vertebral vessels was normal.The electroencephalogram was also normal, as was the noncontrast magnetic resonance imaging (MRI) brain.Other laboratory investigations, such as serum electrolytes, serum calcium, albumin, magnesium, and thyroid stimulating hormone (TSH), were normal.

Authors

Publication Details

Journal
Indian Journal of Critical Care Case Report
Published
2024-12-30
DOI
https://doi.org/10.5005/jp-journals-11006-0148
Primary Topic
Neurological Complications and Syndromes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ondansetron as a Cause of Transient Blindness: A Case Report

Navin Kaushal, Ravi Jindal, Guneet Singh, Sumeet Kumar Jhingan
Indian Journal of Critical Care Case Report
Neurological Complications and Syndromes
article

Ondansetron as a Cause of Transient Blindness: A Case Report

Navin Kaushal, Ravi Jindal, Guneet Singh, Sumeet Kumar Jhingan
article en

Abstract

REPORTpantoprazole 40 mg IV twice a day, injection ondansetron 4 mg thrice a day, tablet amlodipine 10 mg twice a day, and tablet baclofen 25 mg twice a day.The patient was improving with the treatment and was mobilized out of bed on the 3rd day of admission.However, on the 4th day of admission, the patient suddenly complained of a loss of vision.Her vitals were normal, and no other abnormality was detected.The patient had been administered intravenous ondansetron 4 mg 10 minutes prior to the onset of blindness.The patient experienced vertigo and sudden blackout, with everything appearing greenish.A neurology consultation was sought.The neurological examination was normal, other than the blindness.However, the patient was agitated and restless.A provisional diagnosis of encephalopathy/acute psychosis was made.Color Doppler of carotid and vertebral vessels was normal.The electroencephalogram was also normal, as was the noncontrast magnetic resonance imaging (MRI) brain.Other laboratory investigations, such as serum electrolytes, serum calcium, albumin, magnesium, and thyroid stimulating hormone (TSH), were normal.

Indian Journal of Critical Care Case ReportVol. 4(1)
Gender equality
Openalex Percentile: Top 67%
Neurological Complications and Syndromes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ondansetron as a Cause of Transient Blindness: A Case Report — Navin Kaushal, Ravi Jindal, et al. · Indian Journal of Critical Care Case Report (2024) | TGRS Research Map | TGRS